Improving safety of fluoropyrimidine chemotherapy by individualizing treatment based on dihydropyrimidine dehydrogenase activity - Ready for clinical practice?

Improving safety of fluoropyrimidine chemotherapy by individualizing treatment based on dihydropyrimidine dehydrogenase activity - Ready for clinical practice?

Item
http://www.wikidata.org/entity/Q38944983
Chemotherapy Induces Oral Mucositis in Mice Without Additional Noxious Stimuli.Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients.Next-Generation Sequencing in Diagnostic Pathology.DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update.DPYD genotype-guided fluoropyrimidines dose: is it ready for prime time?DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer.
P2860

Improving safety of fluoropyrimidine chemotherapy by individualizing treatment based on dihydropyrimidine dehydrogenase activity - Ready for clinical practice?

Item
http://www.wikidata.org/entity/Q38944983
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Improving safety of fluoropyri ...... - Ready for clinical practice?
@en
type
label
Improving safety of fluoropyri ...... - Ready for clinical practice?
@en
prefLabel
Improving safety of fluoropyri ...... - Ready for clinical practice?
@en
P1433
P1476
P2093
P304
P31
P356
P478
P577
P698
P356
P1433
P1476
Improving safety of fluoropyri ...... - Ready for clinical practice?
@en
P2093
P304
P31
P356
10.1016/J.CTRV.2016.08.002
P478
P577
P698